PLANTS

Language selector

Accessibility tools

Navigation path

Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
Legislation 2009/37 ,
Reg.(EU) No 2017/555 ,
Reg.(EU) No 540/2011
   
Date of approval 01/12/2009 Expiration of approval 30/11/2021
RMS

Co-RMS
FI

SE
Risk Assessment EFSA
Category HB    
Remarks The classification of the tefuryl variant is reported in the specific entry Quilofop-P-tefuryl

The original Co-RMS was UK.
Authorisation at national level
Authorised in In progress for
AT, BE, BG, CY, CZ, DE, EE, EL, ES, FI, FR, HR, HU, IE, IT, LT, LU, LV, MT, NL, PL, PT, RO, SI, SK, UK
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
Legislation Annexes
  • Quizalofop, incl. quizalfop-P
    MRLs Annex IIIA
Classification Reg. 1272/2008
No classification
Toxicological information
Reference values Source Remark
ADI  
ARfD  
AOEL  
ADI 0.013 EFSA 08 Tox Info for Quizalofop-P-tefuryl 
ARfD 0.1 EFSA 08 Tox Info for Quizalofop-P-tefuryl 
AOEL 0.01 EFSA 08 Tox Info for Quizalofop-P-tefuryl 
Other
 
Legend
  • RMS:Rapporteur Member State
  • Co-RMS:Co-Rapporteur Member State
  • ADI:Acceptable daily intake
  • ARfD:Acute reference dose
  • AOEL:Acceptable operator exposure level